Concept Page
National Programme for Prevention and Control of Non-Communicable Diseases (NPDCS)
The National Programme for Prevention and Control of Non-Communicable Diseases is a health initiative. It aims to control and prevent non-communicable diseases. Launched in 2010, it focuses on major diseases like diabetes and hypertension.
National Programme for Prevention and Control of Non‑Communicable Diseases (NPDCS) is a centrally‑funded health initiative launched by the Ministry of Health and Family Welfare (MoHFW) in 2010 to curb the rising burden of chronic illnesses such as diabetes, hypertension, cardiovascular disease, cancer, and chronic respiratory conditions. It is distinctive for embedding NCD prevention within the primary‑care framework of the National Health Mission (NHM) and for aligning India’s targets with the World Health Organization’s Global Action Plan to achieve a 25 % reduction in premature mortality by 2025.
Origins / Historical Background
The programme emerged from the 2009 National Health Policy, which identified non‑communicable diseases as the leading cause of death—accounting for roughly 60 % of all mortality in India by 2020. In response, the Union Health Minister announced the NPDCS in the Union Budget of 2010‑11, earmarking an initial allocation of ₹1,000 crore for infrastructure, training, and surveillance. The 2013 amendment to the NHM formally incorporated NPDCS, creating a dedicated NCD cell within the MoHFW and establishing a steering committee chaired by the Union Health Minister. The National Action Plan for NCDs (NAP‑NCD) 2013‑2020, later refreshed for 2021‑2025, set quantitative milestones, including the establishment of 100 district‑level NCD clinics and 500 sub‑district NCD units by 2020.
How It Works / Mechanism
Implementation proceeds through a three‑tiered model: (1) community‑level health promotion via Accredited Social Health Activists (ASHAs) who conduct risk‑factor counseling and organize screening camps; (2) primary‑care integration where sub‑district NCD clinics provide opportunistic screening for blood pressure, blood glucose, and tobacco use; and (3) referral pathways to district NCD units equipped with diagnostic facilities, specialist consultations, and free medicines under the Jan Aushadhi scheme. The programme also mandates a robust surveillance system coordinated by the National Centre for Disease Control (NCDC), which publishes annual reports on incidence, prevalence, and mortality trends for the four major NCD categories. Capacity building is achieved through periodic training of medical officers, nurses, and laboratory technicians, funded by the NHM’s capacity‑building budget of ₹300 crore in 2022‑23.
Key Provisions
Key statutory provisions are embedded in the NHM (Amendment) Act, 2013, Section 12(2), which obliges each state to formulate a State NCD Action Plan aligned with the national framework. The programme mandates: (i) universal screening for adults aged ≥ 30 years for hypertension and diabetes; (ii) provision of at least 100 % of essential NCD medicines listed in the National List of Essential Medicines (NLEM) at primary‑care centres; (iii) establishment of a minimum of one NCD clinic per district with a dedicated NCD physician, a lab technician, and a health educator; and (iv) quarterly reporting of key performance indicators to the MoHFW via the Integrated Health Information Platform (IHIP). Financial provisions stipulate a 15 % earmark of the NHM budget for NCD activities, translating to ₹2,500 crore in the 2021‑22 financial year.
Current Status / Implementation
As of the 2023‑24 review, more than 150 district NCD units and 620 sub‑district clinics are operational, covering 85 % of the population. The programme’s surveillance arm reported a modest decline in age‑standardised mortality from cardiovascular diseases—from 210 per 100,000 in 2015 to 190 per 100,000 in 2022—while diabetes prevalence plateaued at 8.9 % among adults. However, gaps persist: only 42 % of eligible adults have undergone a blood‑pressure check in the past year, and medicine stock‑outs remain a challenge in 18 % of primary‑care centres. Recent policy briefs have called for scaling up digital health tools, such as the NCD‑Mitra mobile app, to improve patient follow‑up and adherence.
Significance
NPDCS is pivotal because it translates global NCD targets into a domestically tailored, multi‑sectoral strategy that links prevention, early detection, and treatment within existing primary‑care networks. The programme’s emphasis on community engagement and free essential medicines directly addresses socioeconomic determinants that amplify risks—illustrated by recent research linking early menopause among South Asian women to heightened cardiovascular disease incidence. By institutionalising NCD care, NPDCS not only aims to reduce premature deaths but also to alleviate the long‑term economic strain of chronic disease management on households and the health system.